Total antioxidant capacity and the severity of the pain in patients with fibromyalgia

Redox Report

Volumn 11, Issue 3, 2006, Pages 131-135

  Altindag, Ozlem ^a   Celik, Hakim ^a  

^a HARRAN UNIVERSITY   (Turkey)

Author keywords

Fibromyalgia; Oxidative stress; Total antioxidant capacity; Total peroxide

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; PEROXIDE; TROLOX C;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FIBROMYALGIA; HUMAN; MALE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT INDICATION; VISUAL ANALOG SCALE; VITAMIN SUPPLEMENTATION;

ADULT; ANOXIA; ANTIOXIDANTS; ASCORBIC ACID; CASE-CONTROL STUDIES; FEMALE; FIBROMYALGIA; FREE RADICALS; HUMANS; MALE; OXIDATIVE STRESS; PAIN; VITAMIN E;

EID: 33746364521     PISSN: 13510002     EISSN: 13510002     Source Type: Journal    
DOI: 10.1179/135100006X116628     Document Type: Article

References (35)

1. Nampiaparampil DE, Shmerling RH. A Review of fibromyalgia. Am J Manag Care 2004; 10: 794-800.
2. Inanici F, Yunus MB. History of fibromyalgia: past to present. Curr Pain Headache Report 2004; 8: 369-378.
3. Jeschonneck M, Grohmann G, Hein G, Sprott H. Abnormal microcirculation and temperature in skin above tender points in patients with fibromyalgia. Rheumatology 2000; 39: 917-921.
4. Lund N, Bengtsson A, Thorborg P. Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 1986; 15: 165-173.
5. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-119.
6. Halliwell B. Free radicals, antioxidants and human disease: curiosity, cause or consequence. Lancet 1994; 344: 721-724.
7. Franco AA, Odom RS, Rando TA. Regulation of antioxidant enzyme gene expression in response to oxidative stress and during differentiation of mouse skeletal muscle. Free Radic Biol Med 1999; 27: 1122-1132.
8. Schlesier K, Harwat B, Bohm V Bitsch R. Assessment of antioxidant activity by using different in vitro methods. Free Radic Res 2002; 36: 177-187.
9. Prior RL, Cao G. In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 1999; 27: 1173-1181.
10. Yeni E, Gulum M, Selek S et al. Comparison of oxidative/ant oxidative status of penile corpus cavernosum blood and peripheral venous blood. Int J Impot Res 2005; 17: 19-22.
11. Harma M, Harma M, Erel O. Oxidative stress in patients with preeclampsia. Am J Obstet Gynecol 2005; 2: 656-657.
12. Harma M, Harma M, Erel O. Measurement of the total antioxidant response in preeclampsia with a novel method. Eur J Obstet Gynecol Reprod Biol 2005; 118: 47-51.
13. Scheibmeir HD, Christensen K, Whitaker SH, Jegaethesan J, Clancy R, Pierce JD. A review of free radicals and antioxidants for critical care nurses. Intensive Crit Care Nurs 2005; 21: 24-28.
14. Ali M. The cause of fibromyalgia: the respiratory-to-fermentative shift (the DysOx State) in ATP production. J Integr Med 2003; 8: 135-140.
15. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991; 18: 728-733.
16. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
17. Huskisson EC. Visual analogue scales. In: Melzack R. (ed) Pain measurement and assessment. Newyork, PA: Raven, 1983; 33-37.
18. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37: 277-285.
19. Ahn MR, Kumazawa S, Hamasaka T, Bang KS, Nakayama T. Antioxidant activity and constituents of propolis collected in various areas of Korea. J Agric Food Chem 2004; 52: 7286-7292.
20. Harma M, Harma M, Erel O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 2003; 133: 563-566.
21. Aycicek A, Erel O, Kocyigit A. Increased oxidative stress in infants exposed to passive smoking. Eur J Pediatr 2005; 164: 775-778.
22. Demirbag R, Yilmaz R, Erel O. The association of total antioxidant capacity with sex hormones. Scand Cardiovasc J 2005; 39: 172-176.
23. Demirbag R, Yilmaz R, Erel O, Gultekin U, Asci D, Elbasan Z. The relationship between potency of oxidative stress and severity of dilated cardiomyopathy. Can J Cardiol 2005; 21: 851-855.
24. Sarban S, Kocyigit A, Yazar M, Isikan UE. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 2005; 38: 981-986.
25. Yanik M, Erel O, Kati M. The relationship between potency of oxidative stress and severity of depression. Acta Neuropsychiatrica 2004; 16: 200-203.
26. Prior RL, Wu XL, Schaich K. Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements. J Agric Food Chem 2000; 53: 4290-4302.
27. Southorn PA, Powis G. Free radicals in medicine. Involvement in human disease. Mayo Clin Proc 1988; 63: 390-408.
28. Ma TY, Hollander T, Freeman D. Oxygen free radical injury of IEC 18 small intestinal cell monolayers. Gastroenterology 1991; 100: 1533-1543.
29. Bagis S, Tamer L, Sahin G et al. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int 2005; 25: 188-190.
30. Fassbender HG, Wegner K. Morphology and pathogenesis of soft tissue rheumatism. Z Rheumaforsch 1973; 32: 355-374.
31. Bengtsson A, Henriksson KG, Larsson J. Reduced high energy phosphate levels in the painful muscles of patients with primary fibromyalgia. Arthritis Rheum 1986; 15: 1-6.
32. Eisinger J, Plantamura A, Marie PA, Ayavou T. Selenium and magnesium status in fibromyalgia. Magnes Res 1994; 7: 285-258.
33. Sprott H, Salemi S, Gay RE et al. Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres. Ann Rheum Dis 2004; 63: 245-251.
34. Yunus MB, Kalyan-Raman UP, Kalyan-Raman K, Masi AT. Pathologic changes in muscle in primary fibromyalgia syndrome. Am J Med 1986; 81: 38-42.
35. Bramwell B, Ferguson S, Scarlett N, Macintosh A. The use of ascorbigen in the treatment of fibromyalgia patients: a preliminary trial. Altern Med Rev 2000; 5: 455-462.